Literature DB >> 23810298

Prevention of vascular access hand ischemia using the axillary artery as inflow.

William Jennings1, Robert Brown, John Blebea, Kevin Taubman, Ryan Messiner.   

Abstract

BACKGROUND: Avoiding dialysis access-associated ischemic steal syndrome (DASS) in patients with upper extremity peripheral vascular occlusive disease while creating a functional hemodialysis vascular access may be challenging. We constructed an autogenous access with primary proximalization of the arterial inflow to prevent hand ischemia in patients at high risk for this complication.
METHODS: Patients requiring hemodialysis access with physical findings suggesting a high risk of access-related hand ischemia (absent radial, ulnar, and brachial palpable pulses associated with small calcified vessels by ultrasound examination) underwent a primary arteriovenous fistula transposition procedure utilizing the axillary artery for inflow. The arteriovenous fistula was either a reversed flow basilic vein transposition supplemented by valvulotomy (n = 22); a translocated reversed basilic vein (n = 4); a cephalic vein harvested into the forearm and placed in a loop configuration for axillary artery inflow (n = 3); or a translocated reversed saphenous vein (n = 1).
RESULTS: Thirty patients with a mean age of 60 years (range, 31-83 years) underwent successful primary axillary artery inflow procedures during a 3-year period. Of these, 23 (77%) were female and 25 (83%) were diabetic. Twenty-one (70%) had previous vascular access procedures and 10 (33%) were obese. No patient developed postoperative ischemia. Three individuals died 2, 14, and 19 months following surgery, none related to vascular access. Three accesses failed after 1, 5, and 7 months and could not be salvaged. Life-table primary, primary assisted, and cumulative patency rates were 57%, 78%, and 87% respectively at 1 year with a mean follow-up of 7 months (range, 1-25 months). Cephalic vein outflow was associated with fewer access failures, fewer interventions postoperatively, and lower rates of arm swelling (P < .01).
CONCLUSIONS: Creating a basilic vein transposition for vascular access utilizing axillary artery inflow is a good option for patients with severe peripheral vascular disease. It offers a high patency rate and the prevention of DASS. Retrograde basilic vein outflow through the median cubital and cephalic vein is associated with the best outcome and is the recommended configuration.
Copyright © 2013 Society for Vascular Surgery. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23810298     DOI: 10.1016/j.jvs.2013.05.006

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  5 in total

1.  Access-related hand ischemia and the Hemodialysis Fistula Maturation Study.

Authors:  Thomas S Huber; Brett Larive; Peter B Imrey; Milena K Radeva; James M Kaufman; Larry W Kraiss; Alik M Farber; Scott A Berceli
Journal:  J Vasc Surg       Date:  2016-07-29       Impact factor: 4.268

2.  Alternative prosthetic vascular access creation using subscapular artery as inflow to prevent dialysis access related steal syndrome.

Authors:  Dan Song; Sangchul Yun
Journal:  Ann Surg Treat Res       Date:  2015-05-14       Impact factor: 1.859

3.  Maintaining a viable vascular access for hemodialysis in an elderly person with diabetes: a journey to live, not just to stay alive.

Authors:  Debi Cowan; Lindsay Smith; Josephine Chow
Journal:  Clin Case Rep       Date:  2016-01-04

Review 4.  Operative Techniques to Prevent Dialysis Access-associated Steal Syndrome in High-risk Patients Undergoing Surgery for Hemodialysis Access: A Systematic Review.

Authors:  Fareed A Shaikh; Nadeem Siddiqui; Noman Shahzad; Amna Riaz; Ziad Sophie
Journal:  Cureus       Date:  2019-11-06

5.  Prophylactic distal revascularization with interval ligation and simultaneous arteriovenous fistula creation in high-risk patients.

Authors:  Andrew E Leake; Steven A Leers; Thomas Reifsnyder; Ellen D Dillavou
Journal:  J Vasc Surg Cases       Date:  2015-04-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.